
Neutrophil Extracellular Traps in Neuropathic Pain: Neuroimmune Mechanisms, Biomarkers and Therapeutic Perspectives
J Pain Res. 2026 Nov 12;19:640306. doi: 10.2147/JPR.S640306. eCollection 2026.
ABSTRACT
Neuropathic pain (NP) is a chronic pain syndrome caused by lesions or diseases affecting the somatosensory nervous system. Current therapeutic strategies remain largely symptomatic and provide limited clinical efficacy, highlighting the urgent need for mechanism-based therapeutic targets. Neutrophil extracellular traps (NETs), originally identified as key effector structures of innate immunity, have recently emerged as important regulators of neuroinflammation beyond their antimicrobial functions. Increasing evidence suggests that NETs may contribute to the initiation, maintenance, and chronification of neuropathic pain through their associations with neurovascular dysfunction, inflammatory amplification, and neuroimmune crosstalk. However, the mechanistic roles and translational significance of NETs in neuropathic pain have not been comprehensively integrated. In this review, we summarize the biological characteristics of NETs and critically discuss recent advances in their involvement in neuropathic pain. We highlight the mechanisms by which NETs remodel the neural microenvironment, impair microvascular homeostasis, amplify inflammatory signaling, and promote neuroimmune interactions, thereby facilitating the transition from peripheral nerve injury to central sensitization. Furthermore, we propose a unified pathogenic cascade, neural injury → NET formation → neural microenvironment remodeling → inflammatory amplification → neuroimmune crosstalk → central sensitization → pain chronification. Based on these observations, we propose that NETs may function as a neurovascular-immune interface linking peripheral immune activation, vascular dysfunction, and neuroinflammatory signaling during neuropathic pain. This framework provides a mechanistic explanation for the shared pathological features observed across diverse neuropathic pain conditions. Finally, we summarize current evidence regarding NET-related biomarkers and NET-targeted therapeutic strategies and discuss their potential applications in precision diagnosis, patient stratification, and mechanism-based interventions. Elucidating the NET-mediated neurovascular-immune regulatory network will deepen our understanding of neuropathic pain pathogenesis and provide a theoretical basis for the development and clinical translation of precision therapeutics targeting NETs.
PMID:43042021 | PMC:PMC13772784 | DOI:10.2147/JPR.S640306
